StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck consolidated Japan Revenue ($M) ($M)

Postgres DB segment_values

QuarterlyAnnual
Latest, FY2025
2,711
Period ended Dec 31, 2025
Change on a year earlier
-17.3%
3,280 in FY2024
History
15 years
Since FY2011
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated Japan Revenue ($M) ($M)Year on yearSource
FY2025Dec 31, 20252,711-17.3%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 20243,280+3.7%Form 10-K (filed 2025-02-25) ↗
FY2023Dec 31, 20233,164-12.8%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 20223,629+33.1%Form 10-K (filed 2023-02-24) ↗
FY2021Dec 31, 20212,726+4.8%Form 10-K (filed 2022-02-25) ↗
FY2020Dec 31, 20202,602-0.3%Form 10-K (filed 2022-02-25) ↗
FY2019Dec 31, 20192,609-18.8%Form 10-K (filed 2022-02-25) ↗
FY2018Dec 31, 20183,212+2.9%Form 10-K (filed 2019-02-27) ↗
FY2017Dec 31, 20173,122+9.7%Form 10-K (filed 2018-02-27) ↗
FY2016Dec 31, 20162,846+6.5%SEC Filing ↗
FY2015Dec 31, 20152,673-23.0%Form 10-K (filed 2016-02-26) ↗
FY2014Dec 31, 20143,471-14.2%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 20134,044-20.7%Form 10-K (filed 2014-02-27) ↗
FY2012Dec 31, 20125,102+5.5%Form 10-K (filed 2014-02-27) ↗
FY2011Dec 31, 20114,835–Form 10-K (filed 2014-02-27) ↗

Cite this data

StockData. (2026). Merck Consolidated Japan Revenue ($M) ($M), annual FY2011–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_geo_jp_rev

See every metric in the Merck KPI table. Data updated Oct 26, 2026.